Michael Gale, Jr.
Dr. Gale a Professor of Immunology and the Director of the UW Center for Innate Immunity and Immune Disease (CIIID). He also serves as a Core Staff member of the Infectious Disease and Translational Medicine Division of the Washington National Primate Research Center and Associate Director of the UW Center for Emerging and Re-emerging Infectious Disease (CERID). He leads a research program aimed to define how virus and host trigger and control innate immunity for the outcome of virus infection and immunity, including studies of the SARS-CoV-2, flaviviruses, including West Nile virus, dengue virus, Japanese encephalitis virus, Zika virus, and hepatitis C virus. His group also studies innate immunity to hepatitis B virus, human immunodeficiency virus, influenza A virus, hanta virus, Ebola virus, and coronaviruses. His work also focuses on defining therapeutic targets for immune enhancement and to control pathogenic RNA virus infection, and on defining the immune gene signature and mechanisms of protection of SIV/HIV vaccine clinical trial candidates; He teaches virology, immunology, infectious disease biology, and public health. He serves on the editorial board of several biomedical research journals. His lab is a member of the CIIID and team are experts in innate immunity to RNA virus infection.